Schonfeld Strategic Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-133,084	Closed	-$2.48M	–	3317
2022 Q1	$2.48M	Sell	133,084 -74,899	-36%	-$1.35M	0.02%	661
2021 Q4	$4.45M	Sell	207,983 -38,205	-16%	-$753K	0.04%	497
2021 Q3	$4.55M	Buy	246,188 +38,841	+19%	+$782K	0.05%	468
2021 Q2	$4.44M	Buy	207,347 +8,564	+4%	+$174K	0.05%	492
2021 Q1	$3.83M	Buy	+198,783	New	+$3.5M	0.05%	500

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Schonfeld Strategic Advisors's OCDX Position: Q2 2022 in Review

Schonfeld Strategic Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 133,084 shares — an estimated $2.48M sold.

Schonfeld Strategic Advisors first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $4.55M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Schonfeld Strategic Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 133,084 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.48M.
Schonfeld Strategic Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Schonfeld Strategic Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.55M in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.